Catalyst Wire Dossier Catalyst Wire Dossier

semaglutide (Wegovy)

semaglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for semaglutide (Wegovy), covering 2024-12-16 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss [Phase 4]

See pricing